MARK INOCENCIO: Open Payments
NPI 1134568702 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 15 payments from 7 companies in 2025. Trend: 2023 $149 · 2024 $312 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 5 | $179 |
| Xeris Pharmaceuticals, Inc. | 4 | $71 |
| Medtronic, Inc. | 1 | $49 |
| Amgen Inc. | 2 | $37 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: BRIXADI, RECORLEV, MINIMED 780G, EVENITY, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
